Fung ET

No ORCID on file · 4 papers in corpus · active 2011-2014
2014
Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.
Proteomics. Clinical applications ·doi:10.1002/prca.201400063

PurposeOvarian cancer is a devastating disease and biomarkers for its early diagnosis are urgently required. Serum may be a valuable source of biomarkers that may be revealed by proteomic profiling. Herein, complementary serum protein profi…

2014
Early inflammatory response in epithelial ovarian tumor cyst fluids.
Cancer medicine ·doi:10.1002/cam4.282

Mortality rates for epithelial ovarian cancer (EOC) are high, mainly due to late-stage diagnosis. The identification of biomarkers for this cancer could contribute to earlier diagnosis and increased survival rates. Given that chronic inflam…

2012
Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers.
Clinical proteomics ·doi:10.1186/1559-0275-9-14

UnlabelledBackgroundWe aimed to investigate the use of ovarian cyst fluid as a source for biomarker discovery and to find novel biomarkers for use in the diagnosis of epithelial ovarian tumors.ResultsOvarian cyst fluids from 218 women were …

2011
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2011.06.002

ObjectiveThe low prevalence of ovarian cancer demands both high sensitivity (>75%) and specificity (99.6%) to achieve a positive predictive value of 10% for successful early detection. Utilizing a two stage strategy where serum marker(s) pr…